In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

CMV associated tissue-invasive disease is associated with a considerable risk of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Recently, the terminase inhibitor letermovir (LMV) has been approved for prophylaxis of CMV infection in HSCT. We hereby report a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jochen J Frietsch, Detlef Michel, Thomas Stamminger, Friederike Hunstig, Sebastian Birndt, Ulf Schnetzke, Sebastian Scholl, Andreas Hochhaus, Inken Hilgendorf
Formato:	Artigo
Idioma:	Inglês
Publicado em:	PAGEPress Publications 2019-01-01
Colecção:	Mediterranean Journal of Hematology and Infectious Diseases
Assuntos:	Cytomegalovirus hematopoietic stem cell transplantation reactivation letermovir
Acesso em linha:	https://www.mjhid.org/index.php/mjhid/article/view/3708
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!